Abbott Rapid Diagnostics A/S: Financial statements 2023
CVR: 24204650
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Abbott Rapid Diagnostics A/S (CVR 24204650) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 6,159,276 and a net result of DKK 1,220,889 compared with DKK 697,158 the year before. That is a decrease of 40% compared with the year before. Equity in the 2023 report amounted to DKK 30,806,091. The solvency ratio was 89.3%. The company had 5 employees in the financial year.
- Gross Profit
- DKK 6,159,276
- Profit/Loss
- DKK 1,220,889
- Equity
- DKK 30,806,091
- Total Assets
- DKK 34,482,046
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 6.2 mio. | 1.2 mio. | 30.8 mio. | 5 |
| 2022 | - | 10.3 mio. | 697 t. | 29.6 mio. | 12 |
| 2021 | - | 10 mio. | 810 t. | 28.9 mio. | 12 |
| 2020 | - | 10 mio. | 647 t. | 28.1 mio. | 12 |
| 2019 | - | 15.3 mio. | 2.8 mio. | 27.4 mio. | 17 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Abbott Rapid Diagnostics A/S has published its annual report for 2022. Gross profit came to DKK 10,273,041, and the net result was DKK 697,158.
As of June 19, 2023, Fredrik Björn Anders Björnulfson has joined the board of directors of Abbott Rapid Diagnostics A/S.
As of June 19, 2023, Petter Aspaas has left the board of directors of Abbott Rapid Diagnostics A/S.
As of June 19, 2023, Berit Landsend-Holo is registered as adm. dir. of Abbott Rapid Diagnostics A/S.
As of June 19, 2023, Henrik Kjeldsmark Jensen has stepped down as adm. dir. of Abbott Rapid Diagnostics A/S.
About Abbott Rapid Diagnostics A/S
Abbott Rapid Diagnostics A/S is a Danish company of the type Aktieselskab based in København S, founded in 1999. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ALERE A/S and MEDINOR A/S. The management consists of Berit Landsend-Holo. The board consists of Fredrik Björn Anders Björnulfson (chair), Berit Landsend-Holo and Mark Andrew Koewler. The company is owned by St. Jude Medical International Holding. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 2,286,557 and a net result of DKK 561,997 compared with DKK 854,423 the year before. Equity in the 2025 report amounted to DKK 32,222,511.